FDA Inspection 1000383 — NVE Pharmaceuticals, Inc.

NVE Pharmaceuticals, Inc. — FEI 3000205552

The FDA completed an inspection of NVE Pharmaceuticals, Inc. on Dec 14, 2016 in Andover, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 1 citation was issued during this inspection. Product area: Food/Cosmetics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Dec 14, 2016
Fiscal Year
2017
Product Type
Food/Cosmetics
Project Area
Food Composition, Standards, Labeling and Econ
Location
Andover, NJ (United States)

Citations

IDCFRDescription
1586921 CFR 111.75(c)Specifications met - verify; finished batch

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.